Bevantolol

Bevantolol
Systematic (IUPAC) name

(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
Legal status	℞ (Prescription only)
Identifiers
CAS Number	59170-23-9^Y
ATC code	C07AB06 (WHO)
PubChem	CID 2372
DrugBank	DB01295^Y
ChemSpider	2282^Y
UNII	34ZXW6ZV21^Y
ChEBI	CHEBI:238698^Y
ChEMBL	CHEMBL314010^Y
Chemical data
Formula	C₂₀H₂₇NO₄
Molar mass	345.43 g/mol
Chirality	Racemic mixture
SMILES O(c1ccc(cc1OC)CCNCC(O)COc2cc(ccc2)C)C
InChI InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3^Y Key:HXLAFSUPPDYFEO-UHFFFAOYSA-N^Y
(verify)

Bevantolol (INN) is a drug that acts as both a beta blocker and a calcium channel blocker.^[1]

References

↑ Warltier DC, Gross GJ, Jesmok GJ, Brooks HL, Hardman HF (1980). "Protection of Ischemic Myocardium: Comparison of Effects of Propranolol, Bevantolol and N-Dimethyl Propranolol on Infarct Size Following Coronary Artery Occlusion in Anesthetized Dogs". Cardiology 66.

Beta blockers (C07)

β, non-selective	Alprenolol Bopindolol Bupranolol Carteolol Cloranolol Mepindolol Nadolol Oxprenolol Penbutolol Pindolol/Iodopindolol Propranolol Sotalol Tertatolol Timolol

β₁-selective	Acebutolol Atenolol Betaxolol Bevantolol Bisoprolol Celiprolol Epanolol Esmolol Metoprolol Nebivolol Practolol S-Atenolol Talinolol

β₂-selective	Butaxamine

α₁- + β-selective	Arotinolol Carvedilol Labetalol

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.